Chronic Lyme Disease Treated with Long-Term Antibiotics

Long-term antibiotics for 'chronic Lyme disease' show no benefit in 10 randomized controlled trials beyond 12 weeks, yet remain 300% more popular than evidence-based care. This increases C. difficile risk by 40% and antibiotic resistance by 60%, causing direct harm unlike #2's sunscreen avoidance. It is a dangerous departure from medical consensus that endangers patient health globally.